Keeping you up to date on recent developments in cardiology, including: Modeling the post-infarct heart; Researchers: Cancer immunotherapy poses threat to heart muscle; Lighting up the path for heart procedures.
Wayne, Pa.-based Intact Vascular Inc. has secured U.S. FDA approval for the first peripheral vascular implant to repair below-the-knee (BTK) post-angioplasty dissections. The company expects to begin shipping units of the Tack endovascular system (4F) in about two weeks.
Keeping you up to date on recent developments in cardiology, including: women can reduce stroke risk; Researchers see promise as stroke-damaged rat brains are repaired; Questions raised over blood pressure devices for home monitoring.
Physicians who perform a variety of device implant procedures face a difficult choice in determining whether a patient should be treated. A new article in the Journal of the American College of Cardiology (JACC) recommends that patients who ordinarily would be candidates for surgical aortic valve replacement (SAVR) might instead be referred for the transcatheter alternative.
Abbott Laboratories, of Abbott Park, Ill., reported that its Triclip transcatheter tricuspid valve repair system has received the CE mark. The device is a nonsurgical treatment for people with tricuspid regurgitation (TR), and, according to the company, it is the first minimally invasive, clip-based tricuspid valve repair device to be commercially available. The Triclip is delivered to the heart through the femoral vein in the leg and works by clipping together a portion of the leaflets of the tricuspid valve to reduce the backflow of blood.
BOGOTA, Colombia – Alivecor Inc., of Mountain View, Calif., is taking its Kardiamobile solution to capture medical-grade ECGs to the Mexican market after receiving clearance from the Comisión Federal para la Protección contra Riesgos Sanitarios, that country’s health care authority.
Keeping you up to date on recent developments in cardiology, including: Patient data registry aims to give insights for care, adverse cardiovascular outcomes; Research: Medicare changes could boost TAVR access; Muscle protein serves essential role in blood clotting during heart attack.
Results of a study presented at the American College of Cardiology's Annual Scientific Session on March 29 demonstrated “excellent” outcomes following transcatheter aortic valve replacement (TAVR) using the Medtronic plc Evolut in low surgical risk patients with bicuspid aortic valve stenosis.
Results of the pivotal Spyral-HTN OFF MED study presented at the American College of Cardiology's Annual Scientific Session on March 29 demonstrated significant reduction in blood pressure three months after renal denervation (RDN) in patients with unmedicated hypertension.
Keeping you up to date on recent developments in cardiology, including: Size of a dog heart affects both vortex flow and pressure difference in the heart; Ultrasound localizes arrhythmias; High temps boost heart-related deaths.
RSS
